Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4734-4737

  Mattner, Frank ^a,d   Ozmen, Laurence ^a   Podlaski, Frank J ^b   Wilkinson, Victoria L ^b   Presky, David H ^b   Gately, Maurice K ^b   Alber, Gottfried ^a,c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b HOFFMANN LA ROCHE INC   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 P 40; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SHWARTZMAN PHENOMENON;

EID: 0030817861     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4734-4737.1997     Document Type: Article

References (28)

1. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recomhinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. F.xp. Med. 173:1029-1032.
2. Basu, M., J. L. Pace, D. M. Pinson, M. P. Hayes, P. P. Trotta, and S. W. Russel. 1988. Purification and partial characterization of a receptor protein for mouse interferon-γ. Proc. Natl. Acad. Sci. USA 85:6282-6286.
3. Billiau, A. 1988. Gamma-interferon: the match that lights the fire? Immunol. Today 9:37-10.
4. Car, D. B., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437-1444.
5. Cerami, A., Y. Ikeda, N. Le Trang, P. J. Hotez, and B. Beutler. 1985. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunol. Lett. 11: 173-177.
6. Cherwinski, H. M., J. II. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. 3. Further differences in lymphokine synthesis between Till and TH2 clones revealed by RNA hybridisation, functionally monospecific bioassays and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
7. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis alpha. J. Immunol. 149:1666-1670.
8. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76:5939-5943.
9. Gately, M. K., D. M. Carvajal, S. E. Connaughton, S. Gillessen, R. R. Warrier, K. D. Kolinsky, V. L. Wilkinson, C. M. Dwyer, G. F. Higgins, F. J. Podlaski, D. A. Faherty, P. C. Familletti, A. S. Stern, and D. H. Presky. 1996. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. N. Y. Acad. Sci. 795:1-12.
10. Gately, M. K., A. G. Wolitzky, P. M. Quinn, and R. Chizzonite. 1992. Regulation tit human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143:127-142.
11. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, U. L. Stremlo, P. C. Famillelti, U. Gubler, D. II. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL.-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206.
12. Heinzel, F. P., A. M. Hujer, F. N. Ahmed, and R. M. Rerko. 1997. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158:4381-1388.
13. Heinzel, F. P., R. M. Rerko, P. Ling, J. Hakimi, and D. Schoenhaut. 1494. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62:4244-4249.
14. Lesslauer, W., H. Tabuchi, R. Gentz, M. Brockhaus, E. J. Schlaeger, G. Grau, P. F. Piguet, P. Pointaire, P. Vassalli, and H. Loetscher. 1991 Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality Eur. J. Immunol. 21:2883-2886.
15. Magram, J., S. E. Connaughton, R. R. Warner, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471-481.
16. Mattner, F., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Schmitt, E. Rüde, and T. Germann. 1993. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J. Immunol. 23:2202-2208.
17. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, S. Fukuda, and M. Kurimoto. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647-1651.
18. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Tongue, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91.
19. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, interferon γ, and tumor necrosis factor a are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907-915.
20. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wlegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
21. Prat, M., G. Gribaudo, P. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine gamma interferon. Proc. Natl. Acad. Sci. USA 81:4515-1519.
22. Rothe, J., W. Lesslauer, H. Loetscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
23. Starnes, H. F., M. K. Pearce, A. Tewari, J. H. Yim, J. Zou, and J. S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J. Immunol. 145:4185-4191.
24. Thomas, L., and R. A. Good. 1952. Studies on the generalized Shwartzman reaction. I. General observations concerning the phenomenon. J. Exp. Med. 96:605-611.
25. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
26. Ulich, T. R., K. Guo, B. Irwin, U. G. Remick, and G. N. Davatelis. 1990. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and inlerleukin-I alpha/beta expression and suppression. Am. J. Pathol. 137:1173-1185.
27. Wilkinson, V. L., R. R. Warrier, T. P. Truitt, P. Nunes, M. K. Gately, and D. H. Presky. 1996. Characterization of anti-mouse II.-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA. J. Immunol. Methods 189:15-24
28. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta. P. Scott, and G. Trinchieri. 1995. lnterleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672-676.